Publications
Selected Publications
1) Kizer JR, Cannon CP, McCabe CH, Mueller HS, Schweiger MJ, Davis VG, Perritt R, Antman EM. Trends in the Use of Pharmacotherapies for Acute Myocardial Infarction Among Physicians Who Design and/or Implement Randomized Trials versus Physicians in Routine Clinical Practice: The MILIS-TIMI Experience. Am Heart J 1999;137:79-92.
2) Kizer JR, Koniaris LS, Edelman JD, St John Sutton MG. Pheochromocytoma Crisis, Cardiomyopathy and Hemodynamic Collapse. Chest 2000;118:1221-1223.
3) Kizer JR, Kimmel SE. The Calcium-Channel Blocker Controversy: Historical Perspective and Lessons for Future Pharmacotherapies. An International Society of Pharmacoepidemiology ‘Hot Topic.' Pharmacoepidemiol Drug Saf 2000;9:25-36.
4) Kizer JR, Gefter WB, deLemos AS, Scoll BJ, Wolfe ML, Mohler ER. Electron Beam Computed Tomography for the Quantification of Aortic Valve Calcification. J Heart Valve Dis 2001;10:361-366.
5) Kizer JR, Kimmel SE. Epidemiologic Review of the Calcium-Channel-Blocker Drugs: An Up-To-Date Perspective on the Proposed Hazards. Arch Intern Med 2001;161:1145-1158.
6) Kizer JR, Silvestry FE, Kimmel SE, Kasner SE, Wiegers SE, Erwin MB, Schwalm SA, Viswanathan MN, Pollard JR, Keane MG, St John Sutton MG. Racial Differences in the Prevalence of Cardiac Sources of Embolism in Subjects with Unexplained Stroke or Transient Ischemic Attack Evaluated by Transesophageal Echocardiography. Am J Cardiol 2002;90:395-400.
7) Kizer JR, Berlin JA, Laskey WK, Schwartz JS, Sauer WH, Krone RJ, Kimmel SE. Limitations of Current Risk-Adjustment Models in the Era of Coronary Stenting. Am Heart J 2003;145:683-692.
8) Kizer JR, Muttreja MR, Matthai WH, McConnell J, Nardonne H, Sonel AF, Keane MG, Wilensky RL. Role of Cardiac Troponin T in the Long-Term Risk-Stratification of Patients Undergoing Percutaneous Coronary Intervention. Eur Heart J 2003;24:1314-1322.
9) Kizer JR. Losartan in the Reduction of Stroke Risk in Patients with Hypertension and Left Ventricular Hypertrophy: A Viewpoint. Am J Cardiovasc Drugs 2003;3:378-379.
10) Kizer JR, Zisman DA, Blumenthal NP, Kotloff RM, Kimmel SE, Strieter RM, Arcasoy SM, Ferrari VA, Hansen-Flaschen J. Association Between Pulmonary Fibrosis and Coronary Artery Disease. Arch Intern Med 2004;164:551-556.
11) Kizer JR, Arnett DK, Bella JN, Paranicas M, Rao DC, Province MA, Oberman A, Kitzman DW, Hopkins PN, Liu JE, Devereux RB. Differences in Left Ventricular Structure Between Black and White Hypertensive Adults. The Hypertension Genetic Epidemiology Network Study. Hypertension 2004;43:1182-1188.
12) Messe SR, Silverman IE, Kizer JR, Homma S, Zahn C, Gronseth G, Kasner SE. Practice Parameter: Recurrent Stroke with Patent Foramen Ovale and Atrial Septal Aneurysm. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2004;62:1042-1050.
13) Kizer JR, Dahlof B, Kjeldsen SE, Beevers G, Ibsen H, Lindholm LH, Julius S, De Faire U, Fyhrquist F, Kristianson K, Nieminen MS, Omvik P, Lederballe-Pedersen O, Oparil S, Wedel H, Edelman JM, Snapinn S, Harris KE, Devereux RB. Stroke Reduction in Hypertensive Adults with Cardiac Hypertrophy Randomized to Losartan Versus Atenolol: The Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension 2005;45:46-52.
14) Kizer JR, Wiebers DO, Whisnant JP, Galloway JM, Welty TK, Lee ET, Best L, Resnick HE, Roman MJ, Devereux RB. Mitral Annular Calcification, Aortic-Valve Sclerosis and Incident Stroke in Adults Free of Clinical Cardiovascular Disease: The Strong Heart Study. Stroke 2005;36:2533-2537.
15) Kizer JR, Devereux RB. Patent Foramen Ovale in Young Adults with Unexplained Stroke.N Engl J Med 2005;353:2361-2372.
16) Kizer JR, Bella JN, Palmieri V, Liu JE, Best LG, Lee ET, Roman MJ, Devereux RB. Left Atrial Diameter as an Independent Predictor of First Clinical Cardiovascular Events in Middle-Aged and Elderly Adults: The Strong Heart Study. Am Heart J 2006; 151:412-418.
17) Dutta T, Karas MG, Segal AZ, Kizer JR. Yield of Transesophageal Echocardiography for Non-Bacterial Thrombotic Endocarditis and Other Cardiac Sources of Embolism in Cancer Patients with Cerebral Ischemia. Am J Cardiol 2006;97:894-898.
18) Kizer JR, Devereux RB. Regression of Left Ventricular Hypertrophy: Lodestar to Stroke Prevention in the Treatment of Hypertension? Am J Hypertens 2006;19:439-442.
19) Karas MG, Francescone S, Segal AZ, Devereux RB, Roman MJ, Liu JE, Hahn RT, Kizer JR. Relation between Mitral Annular Calcification and Complex Aortic Atheroma in Patients with Cerebral Ischemia Referred for Transesophageal Echocardiography. Am J Cardiol 2007;99:1306-1311.
20) Kizer JR, Barzilay JI, Kuller LH, Gottdiener JS. Adiponectin and Risk of Coronary Heart Disease in Older Men and Women. J Clin Endocrinol Metab 2008;93:3357-3364.
21) Doufekias E, Segal AZ, Kizer JR. Cardiogenic and Aortogenic Brain Embolism. J Am Coll Cardiol 2008;51:1049-1059.
22) Kizer JR. Evaluation of the Patient with Unexplained Stroke. Coron Artery Dis 2008;19:535-540.
23) Kizer JR, Krauser DG, Rodeheffer RJ, Burnett JC, Okin PM, Roman MJ, Umans JG, Best LG, Lee ET, Devereux RB. Prognostic Value of Multiple Biomarkers in American Indians Free of Clinically Overt Cardiovascular Disease (From the Strong Heart Study). Am J Cardiol 2009;104:247-253.
24) Kizer JR, Madias C, Wilner B, Vaughan CJ, Mushlin AI, Trushin P, Gotto AM, Pasternak RC.Relation of Different Measures of Low-Density Lipoprotein Cholesterol to Risk of Coronary Artery Disease and Death in a Meta-Regression Analysis of Large-Scale Trials of Statin Therapy. Am J Cardiol 2010;105:1289-1296.
25) Kizer JR, Arnold AM, Strotmeyer ES, Ives DG, Cushman M, Ding J, Kritchevsky SP, Chaves PHM, Hirsch CH, Newman AB. Change in Circulating Adiponectin in Advanced Old Age: Determinants and Impact on Physical Function and Mortality: The Cardiovascular Health Study All Stars Study. J Gerontol A Biol Sci Med Sci 2010:65A:1208-1214.
26) Kizer JR, Biggs ML, Ix JH, Mukamal KJ, Zieman SJ, de Boer IH, Mozaffarian D, Barzilay JI, Strotmeyer ES, Luchsinger JA, Elkind MSV, Longstreth WT, Kuller LH, Siscovick DS. Measures of Adiposity and Future Risk of Ischemic Stroke and Coronary Heart Disease in Older Men and Women. Am J Epidemiol 2011;173:10-25.
27) Kizer JR, Arnold AM, Jenny NS, Cushman M, Strotmeyer ES, Ives DG, Ding J, Kritchevsky SP, Chaves PHM, Hirsch CH, Newman AB. Longitudinal Changes in Adiponectin and Inflammatory Markers and Relation to Survival in the Oldest Old: The Cardiovascular Health Study All Stars Study. J Gerontol A Biol Sci Med Sci 2011;66:1100-1107.
28) Djousse L, Bartz TM, Ix JH, Zieman SJ, Delaney JA, Mukamal KJ, Gottdiener JS, Siscovick DS, Kizer JR. Adiposity and Incident Heart Failure in Older Adults: The Cardiovascular Health Study. Obesity (In press.)
29) Kizer JR, Arnold AM, Benkeser D, Ix JH, Djousse L, Zieman SJ, Barzilay JI, Tracy RP, Mantzoros CS, Siscovick DS, Mukamal KJ. Total and High-Molecular-Weight Adiponectin and Risk of Incident Diabetes in Older People. Diabetes Care (In press.)
30) Karas MG, Devereux RB, Wiebers DO, Whisnant JP, Best LG, Lee ET, Howard BV, Roman MJ, Umans JG, Kizer JR. Incremental Value of Biochemical and Echocardiographic Measures in Prediction of Ischemic Stroke: The Strong Heart Study. Stroke (In press.)
31) Kizer JR, Umans JG, Zhu J, Devereux RB, Wolfert RL, Lee ET, Howard BV. Lipoprotein-Associated Phospholipase A2 Mass and Activity and Risk of Cardiovascular Disease in a Population with High Prevalences of Obesity and Diabetes: The Strong Heart Study. Diabetes Care (In press.)
